Skip to main content
Top
Published in: Techniques in Coloproctology 12/2018

01-12-2018 | Original Article

Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis

Authors: N. Alhassan, M. Trepanier, C. Sabapathy, P. Chaudhury, A. S. Liberman, P. Charlebois, B. L. Stein, L. Lee

Published in: Techniques in Coloproctology | Issue 12/2018

Login to get access

Abstract

Background

Extended thromboprophylaxis after abdominal and pelvic cancer surgery to prevent venous thromboembolic events (VTE) is recommended but adherence is sub-optimal. Identifying patients at highest risk for post-discharge events may allow for selective extended thromboprophylaxis. The aim of our study was to identify the different risk factors of venous thromboembolism for in-hospital and post-discharge events.

Methods

The American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) 2012–2016 database was queried for all patients having colorectal resection. Primary outcome was postoperative VTE occurrence within 30 days. A multinomial logistic regression was performed to identify in-hospital and post-discharge predictors of VTE, adjusting for potential confounders.

Results

Out of 260,258 patients, 5381 (2.1%) developed VTE. A total of 3442 (1.3%) were diagnosed during the initial hospital stay and 1929 (0.8%) post-discharge. Risk factors for in-hospital and post-discharge VTE were different as patients with an in-hospital event were more likely to be older, male, known for preoperative steroid use, have poor functional status, significant weight loss, preoperative sepsis, prolonged operative time, undergoing an emergency operation. In the post-discharge setting, steroid use, poor functional status, preoperative sepsis, and postoperative complications remained significant. Postoperative complications were the strongest predictor of in-hospital and post-discharge VTE. Patients with inflammatory bowel disease had a higher risk of VTE than patients with malignancy for both in-patient and post-discharge events.

Conclusions

Patients at high-risk for post-discharge events have different characteristics than those who develop VTE in-hospital. Identifying this specific subset of patients at highest risk for post-discharge VTE may allow for the selective use of prolonged thromboprophylaxis.
Literature
1.
go back to reference Vedovati MC et al (2014) A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 259(4):665–669CrossRef Vedovati MC et al (2014) A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 259(4):665–669CrossRef
2.
go back to reference Fleming F et al (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery. Dis Colon Rectum 61(1):14–20CrossRef Fleming F et al (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery. Dis Colon Rectum 61(1):14–20CrossRef
3.
go back to reference McLeod RS et al (2001) Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 233(3):438–444CrossRef McLeod RS et al (2001) Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 233(3):438–444CrossRef
4.
go back to reference Gross ME et al (2014) The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis. Dis Colon Rectum 57(4):482–489CrossRef Gross ME et al (2014) The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis. Dis Colon Rectum 57(4):482–489CrossRef
5.
go back to reference Murthy SK, Nguyen GC (2011) Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 106(4):713–718CrossRef Murthy SK, Nguyen GC (2011) Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 106(4):713–718CrossRef
6.
go back to reference Wallaert JB et al (2012) Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum 55(11):1138–1144CrossRef Wallaert JB et al (2012) Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum 55(11):1138–1144CrossRef
7.
go back to reference Gould MK et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl):e227S–e277SCrossRef Gould MK et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl):e227S–e277SCrossRef
8.
go back to reference Fleming FJ et al (2010) How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum 53(10):1355–1360CrossRef Fleming FJ et al (2010) How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum 53(10):1355–1360CrossRef
9.
go back to reference Agnelli G et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89–95CrossRef Agnelli G et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89–95CrossRef
10.
go back to reference Lyman GH et al (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17):2189–2204CrossRef Lyman GH et al (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17):2189–2204CrossRef
11.
go back to reference Lyman GH et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33(6):654–656CrossRef Lyman GH et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33(6):654–656CrossRef
12.
go back to reference Selby LV et al (2016) Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg 222(2):129–137CrossRef Selby LV et al (2016) Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg 222(2):129–137CrossRef
13.
go back to reference Amin AN et al (2011) Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries. Ann Pharmacother 45(9):1045–1052CrossRef Amin AN et al (2011) Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries. Ann Pharmacother 45(9):1045–1052CrossRef
15.
go back to reference Buchberg B et al (2011) Incidence and risk factors of venous thromboembolism in colorectal surgery: does laparoscopy impart an advantage? Arch Surg 146(6):739–743CrossRef Buchberg B et al (2011) Incidence and risk factors of venous thromboembolism in colorectal surgery: does laparoscopy impart an advantage? Arch Surg 146(6):739–743CrossRef
16.
go back to reference Shapiro R, Vogel JD, Kiran RP (2011) Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum 54(12):1496–1502CrossRef Shapiro R, Vogel JD, Kiran RP (2011) Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum 54(12):1496–1502CrossRef
17.
go back to reference Nguyen NT et al (2007) Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Ann Surg 246(6):1021–1027CrossRef Nguyen NT et al (2007) Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Ann Surg 246(6):1021–1027CrossRef
18.
go back to reference Guo Q et al (2017) Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Ann Surg 265(6):1087–1093CrossRef Guo Q et al (2017) Perioperative pharmacological thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. Ann Surg 265(6):1087–1093CrossRef
19.
go back to reference Vendler MMI et al (2017) Incidence of venous thromboembolic events in enhanced recovery after surgery for colon cancer: a retrospective, population-based cohort study. Colorectal Dis 19(11):O393–O401CrossRef Vendler MMI et al (2017) Incidence of venous thromboembolic events in enhanced recovery after surgery for colon cancer: a retrospective, population-based cohort study. Colorectal Dis 19(11):O393–O401CrossRef
20.
go back to reference El-Dhuwaib Y et al (2017) Venous thromboembolism following colorectal resection. Colorectal Dis 19(4):385–394CrossRef El-Dhuwaib Y et al (2017) Venous thromboembolism following colorectal resection. Colorectal Dis 19(4):385–394CrossRef
21.
go back to reference McKenna NP et al (2017) Analysis of postoperative venous thromboembolism in patients with chronic ulcerative colitis: is it the disease or the operation? Dis Colon Rectum 60(7):714–722CrossRef McKenna NP et al (2017) Analysis of postoperative venous thromboembolism in patients with chronic ulcerative colitis: is it the disease or the operation? Dis Colon Rectum 60(7):714–722CrossRef
22.
go back to reference Ali F et al (2018) Elevated venous thromboembolism risk following colectomy for IBD is equal to those for colorectal cancer for ninety days after surgery. Dis Colon Rectum 61(3):375–381CrossRef Ali F et al (2018) Elevated venous thromboembolism risk following colectomy for IBD is equal to those for colorectal cancer for ninety days after surgery. Dis Colon Rectum 61(3):375–381CrossRef
23.
go back to reference Tagalakis V et al (2013) Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 126(9):832 e13–21CrossRef Tagalakis V et al (2013) Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 126(9):832 e13–21CrossRef
24.
go back to reference Gussoni G et al (2013) Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res 131(1):24–30CrossRef Gussoni G et al (2013) Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res 131(1):24–30CrossRef
25.
go back to reference Alsubaie H et al (2015) Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice. Can J Surg 58(5):305–311CrossRef Alsubaie H et al (2015) Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice. Can J Surg 58(5):305–311CrossRef
26.
go back to reference Hanna N et al (2012) Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist 17(9):1191–1197CrossRef Hanna N et al (2012) Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer. Oncologist 17(9):1191–1197CrossRef
27.
go back to reference Fanikos J et al (2013) Hospital costs of acute pulmonary embolism. Am J Med 126(2):127–132CrossRef Fanikos J et al (2013) Hospital costs of acute pulmonary embolism. Am J Med 126(2):127–132CrossRef
28.
go back to reference Merli G et al., Hospital-based costs associated with venous thromboembolism treatment regimens. J Thromb Haemost, 2008. 6(7):1077–1086 Merli G et al., Hospital-based costs associated with venous thromboembolism treatment regimens. J Thromb Haemost, 2008. 6(7):1077–1086
29.
go back to reference Amin AN, Lin J, Ryan A (2010) Need to improve thromboprophylaxis across the continuum of care for surgical patients. Adv Ther 27(2):81–93CrossRef Amin AN, Lin J, Ryan A (2010) Need to improve thromboprophylaxis across the continuum of care for surgical patients. Adv Ther 27(2):81–93CrossRef
30.
go back to reference Merkow RP et al (2014) Adherence with postdischarge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly Medicare beneficiaries. Ann Surg 260(1):103–108CrossRef Merkow RP et al (2014) Adherence with postdischarge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly Medicare beneficiaries. Ann Surg 260(1):103–108CrossRef
31.
go back to reference Bradley CT et al (2010) Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol 17(1):31–39CrossRef Bradley CT et al (2010) Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol 17(1):31–39CrossRef
32.
go back to reference Iannuzzi JC et al (2014) Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg 18(1):60–68CrossRef Iannuzzi JC et al (2014) Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg 18(1):60–68CrossRef
33.
go back to reference Sarasin FP, Bounameaux H (1996) Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery. Arch Surg 131(7):694–697; discussion 698CrossRef Sarasin FP, Bounameaux H (1996) Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery. Arch Surg 131(7):694–697; discussion 698CrossRef
34.
go back to reference Berian JR et al (2018) Association of an enhanced recovery pilot with length of stay in the national surgical quality improvement program. JAMA Surg 153(4):358–365CrossRef Berian JR et al (2018) Association of an enhanced recovery pilot with length of stay in the national surgical quality improvement program. JAMA Surg 153(4):358–365CrossRef
35.
go back to reference Kwon S et al (2011) Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg 213(5):596–603, 603 e1CrossRef Kwon S et al (2011) Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg 213(5):596–603, 603 e1CrossRef
36.
go back to reference Colorectal Writing Group for Surgical (2015) thromboembolic complications and prophylaxis patterns in colorectal surgery. JAMA Surg 150(8):712–720CrossRef Colorectal Writing Group for Surgical (2015) thromboembolic complications and prophylaxis patterns in colorectal surgery. JAMA Surg 150(8):712–720CrossRef
37.
go back to reference Alcalay A et al (2006) Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 24(7):1112–1118CrossRef Alcalay A et al (2006) Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 24(7):1112–1118CrossRef
38.
go back to reference Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375(9715):657–663CrossRef Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375(9715):657–663CrossRef
Metadata
Title
Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis
Authors
N. Alhassan
M. Trepanier
C. Sabapathy
P. Chaudhury
A. S. Liberman
P. Charlebois
B. L. Stein
L. Lee
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Techniques in Coloproctology / Issue 12/2018
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-018-1909-8

Other articles of this Issue 12/2018

Techniques in Coloproctology 12/2018 Go to the issue